tirzepatide and low libido π¨ New Research Alert! π¨ From @sexmedresearch For the first time, a GLP-1/GIP medication (tirzepatide) has been shown to successfully treat Persistent Genital Arousal Disorder (PGAD/GPD) β a rare, painful, often GLP1's and low Libido (Retatrutide,
Description
Sohal and L
PocDoc data generated in 2025 supported this finding with 39% of all individuals screened by PocDoc being overweight and 31% being obese
c The alternative approach they examined was behavioral interventions, nutritional support and a lower-cost medication regimen
.webp)
95% CI: 50.3 to 17.6

Standard Insulin Syringe Capacities 0.3 mL Syringe: 30 units max ideal for small, precise doses under 30 units
For any research protocol, screening for these factors is not just good practice
